Fulltext

B08CheckMate 067: a phase III randomized double-blind study of nivolumab (NIVO) monotherapy or NIVO combined with ipilimumab (IPI) versus IPI monotherapy in previously untreated patients (pts) with advanced melanoma (MEL)

Wolchok, J.D. ; Chiarion-Sileni, V. ; Gonzalez, R. ; Rutkowski, P. ; Grob, J. ; Cowey, C.L. ; Lao, C.D. ; Schadendorf, D. ; Ferrucci, P.F. ; Smylie, M. ; Dummer, R. ; Hill, A. ; Haanen, J. ; Maio, M. ; McArthur, G. ; Yang, A. ; Rollin, L. ; Horak, C. ; Larkin, J. ; Hodi, F.S.

In: Annals of Oncology, 2015, vol. 26, p. vi28-vi28

Add to personal list
    Title
    • B08CheckMate 067: a phase III randomized double-blind study of nivolumab (NIVO) monotherapy or NIVO combined with ipilimumab (IPI) versus IPI monotherapy in previously untreated patients (pts) with advanced melanoma (MEL)
    Author
    • Wolchok, J.D.. Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA
    • Chiarion-Sileni, V.. Oncology Institute of Veneto IRCCS, Padua, Italy
    • Gonzalez, R.. University of Colorado Cancer Center, Denver, CO, USA
    • Rutkowski, P.. Maria Sklodowska-Curie Memorial Cancer Center & Institute of Oncology, Warsaw, Poland
    • Grob, J.. Hospital de la Timone, Marseille, France
    • Cowey, C.L.. Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX, USA
    • Lao, C.D.. University of Michigan, Ann Arbor, MI, USA
    • Schadendorf, D.. Department of Dermatology, University of Essen, Essen, Germany
    • Ferrucci, P.F.. European Institute of Oncology, Milan, Italy
    • Smylie, M.. Cross Cancer Institute, Alberta, Canada
    • Dummer, R.. Universitäts Spital, Zurich, Switzerland
    • Hill, A.. Tasman Oncology Research, Queensland, Australia
    • Haanen, J.. Netherlands Cancer Institute, Amsterdam, The Netherlands
    • Maio, M.. University Hospital of Siena, Siena, Italy
    • McArthur, G.. Peter MacCallum Cancer Centre, Victoria, Australia
    • Yang, A.. Bristol-Myers Squibb, Princeton, NJ, USA
    • Rollin, L.. Bristol-Myers Squibb, Wallingford, CT, USA
    • Horak, C.. Bristol-Myers Squibb, Princeton, NJ, USA
    • Larkin, J.. Royal Marsden Hospital, London, UK
    • Hodi, F.S.. Dana-Farber Cancer Institute, Boston, MA, USA
    Document Type
    • Postprint
    Classification
    • Health
    OAI-PMH Identifier
    • oai:doc.rero.ch:293144